• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Neuland Laboratories Ltd

+ Add to Watchlist

NLL:IN

367.85 INR 11.95 3.36%

As of 07:06:14 ET on 07/30/2014.

Snapshot for Neuland Laboratories Ltd (NLL)

Open: 356.00 Day's Range: 350.00 - 374.45 Volume: 42,226
Previous Close: 355.90 52wk Range: 198.14 - 399.90 1-Yr Rtn: +54.04%

Stock Chart for NLL

No chart data available.
  • NLL:IN 367.85
  • 1D
  • 1M
  • 1Y
355.90
Interactive NLL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NLL

Current P/E Ratio (ttm) 10.5533
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.5701
Earnings Per Share (ttm) 35.0600
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 2,832.60
Shares Outstanding (M) 7.66
30 Day Average Volume 41,602
Price/Book (mrq) 2.3020
Price/Sale (ttm) 0.6040
Dividend Indicated Gross Yield 0.41%
Cash Dividend (INR) 1.5000
Dividend Ex-Date 06/16/2014
5 Year Dividend Growth 0.64%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NLL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for NLL

Neuland Laboratories Limited is a pharmaceutical company, which specializes in bulk drugs and intermediates.

Davuluri Rama Mohan RaoChairman/Managing DirectorDavuluri Sucheth RaoCEO/Executive Director
N S ViswanathanChief Financial OfficerDavuluri Saharsh RaoPres:Contract Research/Executive Dir
More Company Profile & Key Executives for NLL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil